|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100049622 |
|
最近更新日期: Date of Last Refreshed on: |
2021-08-07 05:13:45 |
|
注册时间: Date of Registration: |
2021-08-07 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
经鼻间歇正压通气减少极早早产儿有创呼吸支持需求:单中心随机对照研究 |
|
Public title: |
Nasal intermittent positive pressure ventilation reduces the need for invasive ventilation in very premature infants: a single-center randomized controlled study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
经鼻间歇正压通气减少极早早产儿有创呼吸支持需求:单中心随机对照研究 |
|
Scientific title: |
Nasal intermittent positive pressure ventilation reduces the need for invasive ventilation in very premature infants: a single-center randomized controlled study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王婷婷 |
研究负责人: |
王婷婷 |
|
Applicant: |
Tingting Wang |
Study leader: |
Tingting Wang |
|
申请注册联系人电话: Applicant telephone: |
+86 18721735187 |
研究负责人电话:
Study leader's |
+86 18721735187 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
wangttkycg@126.com |
研究负责人电子邮件: Study leader's E-mail: |
wangttkycg@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市浦东新区高科西路2699号 |
研究负责人通讯地址: |
上海市浦东新区高科西路2699号 |
|
Applicant address: |
2699 Gaoke West Road, Pudong New Area, Shanghai, China |
Study leader's address: |
2699 Gaoke West Road, Pudong New Area, Shanghai, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
同济大学附属第一妇婴保健院 |
||
|
Applicant's institution: |
Shanghai First Maternity and Infant Hospital, School of Medicine,Tongji University,Shanghai 200092,China |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KS21168 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市第一妇婴保健院伦理委员会 |
||
|
Name of the ethic committee: |
Shanghai First Maternal and Infant Hospital Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-05-19 00:00:00 | ||
|
伦理委员会联系人: |
罗烨 |
||
|
Contact Name of the ethic committee: |
Ye Luo |
||
|
伦理委员会联系地址: |
上海市浦东新区高科西路2699号 |
||
|
Contact Address of the ethic committee: |
2699 Gaoke West Road, Pudong New Area, Shanghai, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
同济大学附属第一妇婴保健院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai First Maternity and Infant Hospital, School of Medicine,Tongji University,Shanghai 200092,China |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市浦东新区高科西路2699号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
2699 Gaoke West Road, Pudong New Area, Shanghai, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
院级科研基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
Academy-level scientific research fund |
||||||||||||||||||||||
|
研究疾病: |
新生儿呼吸窘迫综合征 |
||||||||||||||||||||||
|
Target disease: |
NRDS |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
比较经鼻间歇正压通气(NIPPV)与经鼻持续正压通气(NCPAP)作为早期呼吸支持模式治疗胎龄<32 周早产儿呼吸窘迫综合征,减少有创呼吸支持的需求 |
||||||||||||||||||||||
|
Objectives of Study: |
To compare NIPPV and NCPAP as initial respiratory support models for neonatal respiratory distress syndrome(NRDS) in preterm infants born at less than 32 weeks, of gestational age, the need for invasive respiratory support was reduced |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)出生胎龄<32 周,日龄≤6h(胎龄评估根据孕早期超声及孕妇末次月经共同决定); |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Gestational age at birth <32 weeks, age ≤6h (gestational age assessment is determined jointly by ultrasound in the first trimester and the last menstrual period of the pregnant woman); |
||||||||||||||||||||||
|
排除标准: |
(1)入院 6h 内死亡或因床位不足转院; |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Died within 6 hours of admission or transferred due to insufficient beds; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-09-01 00:00:00至 To 2022-10-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2021-09-01 00:00:00 至 To 2022-10-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由统计人员使用计算机生成随机数字表 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Computer-generated sequence of numbers by statistician using computer |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
由发表论文公开 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Open by published papers |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
采用病例记录表(Case Record Form, CRF) |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form(CRF) |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |